How do we measure pulse pressure variation (PPV) and stroke volume variation (SVV)?

How to Measure PPV and SVV

PPV and SVV are measured through continuous monitoring of arterial waveforms during mechanical ventilation, with PPV calculated from arterial blood pressure variations and SVV requiring continuous cardiac output monitoring with pulse wave analysis. 1

Physiological Basis

Both PPV and SVV exploit heart-lung interactions during mechanical ventilation. The cyclic changes in alveolar pressure during positive pressure ventilation influence:

• Right ventricular preload and afterload
• Left ventricular afterload
• Consequently, stroke volume 1

These respiratory-induced variations in stroke volume and pulse pressure serve as dynamic indicators of fluid responsiveness.

Measurement Methods

Pulse Pressure Variation (PPV)

• Direct measurement: PPV can be measured directly from the arterial pressure waveform obtained through invasive arterial line monitoring 2
• Automated calculation: Modern hemodynamic monitors (such as LiDCO Plus) can automatically calculate PPV from the arterial waveform 2
• Formula: PPV represents the percentage change between maximum and minimum pulse pressure values over one respiratory cycle

Stroke Volume Variation (SVV)

• Requires continuous cardiac output monitoring with pulse wave analysis systems 1
• Available through various monitoring platforms:
  • FloTrac/Vigileo system 3
  • LiDCO systems (LiDCORapid™, LiDCO Plus) 4, 2
  • USCOM 1A device (ultrasonic cardiac output monitor) 5
  • Nexfin® device using noninvasive volume clamp plethysmography 6

Critical Prerequisites for Reliable Measurement

For both PPV and SVV to be reliable, specific conditions must be met 1:

Essential Validity Criteria:

1. Tidal volume ≥ 8 mL/kg of predicted body weight
2. Absence of spontaneous breathing activity (fully controlled mechanical ventilation)
3. Regular cardiac rhythm (no arrhythmias)
4. Closed chest and abdomen (surgical factors matter)

Performance Characteristics:

When validity criteria are met:

• PPV achieves pooled AUROC of 0.94 in shock patients with high tidal volume and no spontaneous breathing 1
• Mean threshold for PPV: approximately 10.8% (range 10.6-11.0%) 7
• Mean threshold for SVV: approximately 12.1% (range 11.6-12.7%) 7

When tidal volume < 8 mL/kg:

• PPV performance drops significantly (pooled AUROC 0.74) 1
• High PPV values may still predict fluid responsiveness, but lower values become unreliable
• The 2025 ESICM guidelines suggest against using PPV alone in this scenario 1

Common Pitfalls and Limitations

False Positives (overestimating fluid responsiveness):

• Spontaneous breathing efforts
• Cardiac arrhythmias
• Right ventricular failure

False Negatives (underestimating fluid responsiveness):

• Low tidal volume (< 8 mL/kg)
• Low lung compliance
• Very high respiratory rate
• Open chest or abdomen 1
• Pneumoperitoneum during laparoscopy 4

The Grey Zone Problem:

• 56-57% of patients fall within the "grey zone" where PPV/SVV values are inconclusive 7
• Grey zone ranges vary by clinical context but typically span several percentage points around the threshold
• In the grey zone, alternative methods (passive leg raising test, end-expiratory occlusion test) should be considered 1

Practical Considerations

Vasoactive drug effects 2:

• Vasodilators increase both PPV and SVV (consistent with decreased preload)
• Volume loading decreases both PPV and SVV
• Inotropes and vasoconstrictors do not significantly alter PPV or SVV
• The PPV/SVV ratio remains stable despite vasoactive therapy changes

Monitoring device selection:

• Invasive arterial monitoring provides most reliable PPV measurement
• SVV requires specialized cardiac output monitoring systems
• Noninvasive options (USCOM, Nexfin) show good correlation but may have slightly lower accuracy 5, 6

Clinical Algorithm for Use

1. Verify prerequisites: Controlled mechanical ventilation, Vt ≥ 8 mL/kg, no spontaneous breathing, regular rhythm
2. If prerequisites met: Use PPV (strong recommendation) or SVV (weak recommendation) with thresholds around 10-12% 1
3. If prerequisites not met: Do not rely on PPV/SVV alone; use passive leg raising test or end-expiratory occlusion test instead 1
4. If values in grey zone: Consider functional hemodynamic tests (PLR, end-expiratory occlusion) for definitive assessment
5. Assess response: Confirm fluid responsiveness by measuring actual changes in cardiac output or stroke volume (≥10-15% increase) 1